BLFS
BioLife Solutions Inc
36.80$
-5.3%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 49.1% | 71.7% | 33.6% | 33.0% | 28.7% | – | 34.1% | 35.4% | 36.1% | 32.5% | 36.7% | 35.8% | 35.5% | |
| 50.9% | 28.3% | 66.4% | 67.0% | 71.3% | – | 65.9% | 64.6% | 63.9% | 67.5% | 63.3% | 64.2% | 64.5% | |
| 15.9% | 13.4% | 19.2% | 10.3% | 6.7% | – | 9.2% | 10.7% | 9.7% | 0.4% | 9.6% | 10.4% | 8.2% | |
| 45.9% | 39.6% | 56.4% | 47.3% | 37.1% | – | 48.0% | 44.8% | 43.0% | 56.2% | 44.4% | 37.6% | 44.3% | |
| 116.5% | 68.4% | 84.3% | 73.6% | 76.4% | – | 71.0% | 130.1% | 64.2% | 36.5% | 63.2% | 58.3% | 57.2% | |
| -65.6% | -40.2% | -17.9% | -6.6% | -5.1% | – | -5.1% | -65.5% | -0.3% | 31.0% | 0.1% | 6.0% | 7.2% | |
| 1.9% | 1.5% | 1.1% | 1.8% | 0.9% | – | – | 2.7% | 1.8% | 0.8% | – | – | – | |
| -66.6% | -41.0% | -17.3% | -28.2% | -5.7% | – | -1.8% | -61.8% | 2.5% | 17.9% | 4.5% | 9.7% | 7.8% | |
| 0.5% | -0.1% | 0.1% | 0.0% | -0.1% | – | 0.1% | 0.5% | 0.3% | -0.9% | 0.2% | -148.8% | -41.2% | |
| -123.6% | -40.9% | -55.4% | -105.1% | -5.6% | – | -1.9% | -62.3% | 2.2% | 18.8% | 4.3% | 158.4% | 49.1% | |
| -50.7% | -11.1% | -4.1% | 5.4% | 2.8% | – | 0.7% | -56.4% | 4.4% | 26.1% | 2.6% | 10.2% | 9.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.